Founder, LucidQuest & NexusBrain | Helping BioPharma, HealthTech & Investors see change earlier and decide better

Global
Joined April 2010
Dr Timos Papagatsias retweeted
Are you interested in #GSK #CVC and investment portfolio? Gain now 💡 insights into the 2023 📊 BioPharma (+ Google) Corporate Venture Capital Investment Trends ➡️ dlvr.it/SmgwNn CVCs analyzed: #AbbVie Ventures, #Amgen Ventures, #Astellas… dlvr.it/SmgwP0
1
371
Dr Timos Papagatsias retweeted
Are you interested in #Google Ventures #CVC and investment portfolio? Gain now 💡 insights into the 2023 📊 BioPharma (+ Google) Corporate Venture Capital Investment Trends ➡️ dlvr.it/Smg6PB CVCs analyzed: #AbbVie Ventures, #Amgen Ventures,… dlvr.it/Smg6Ps
1
362
Dr Timos Papagatsias retweeted
Are you interested in #EMDSerono #CVC and investment portfolio? Gain now 💡 insights into the 2023 📊 BioPharma (+ Google) Corporate Venture Capital Investment Trends ➡️ dlvr.it/SmfnSg CVCs analyzed: #AbbVie Ventures, #Amgen Ventures,… dlvr.it/SmfnSv
1
2
404
LucidQuest Updates > RFU and Xcellerant Ventures: Jetstream Partnership | Lucid Diligence Brief dlvr.​it/TW4Yjn #LucidDiligenceBrief #healthinnovation Comment below!
37
LucidQuest Updates > Immunology Strategic Roundup: Rising Evidence Standards | Sep 22—Oct 26, 2026 dlvr.​it/TW4Xm7 #MonthlyStrategicRoundups #OurInsights Comment below!
28
Dr Timos Papagatsias retweeted
Are you interested in #Lilly Ventures #CVC and investment portfolio? Gain now 💡 insights into the 2023 📊 BioPharma (+ Google) Corporate Venture Capital Investment Trends ➡️ dlvr.it/SmfJzP CVCs analyzed: #AbbVie Ventures, #Amgen Ventures,… dlvr.it/SmfK0B
1
1
353
Dr Timos Papagatsias retweeted
Are you interested in #Boehringer Ingelheim #CVC and investment portfolio? Gain now 💡 insights into the 2023 📊 BioPharma (+ Google) Corporate Venture Capital Investment Trends ➡️ dlvr.it/SmfC89 CVCs analyzed: #AbbVie Ventures, #Amgen… dlvr.it/SmfC8T
1
1
395
Dr Timos Papagatsias retweeted
Are you interested in #Bayer #CVC and investment portfolio? Gain now 💡 insights into the 2023 📊 BioPharma (+ Google) Corporate Venture Capital Investment Trends ➡️ dlvr.it/Smdyh4 CVCs analyzed: #AbbVie Ventures, #Amgen Ventures, #Astellas… dlvr.it/SmdyhD
1
1
391
Dr Timos Papagatsias retweeted
Are you interested in #Astellas Ventures #CVC and investment portfolio? Gain now 💡 insights into the 2023 📊 BioPharma (+ Google) Corporate Venture Capital Investment Trends ➡️ dlvr.it/SmdN0J CVCs analyzed: #AbbVie Ventures, #Amgen… dlvr.it/SmdN0Y
1
1
373
Dr Timos Papagatsias retweeted
Are you interested in #Amgen Ventures #CVC and investment portfolio? Gain now 💡 insights into the 2023 📊 BioPharma (+ Google) Corporate Venture Capital Investment Trends ➡️ dlvr.it/Smd7cV CVCs analyzed: #AbbVie Ventures, #Amgen Ventures,… dlvr.it/Smd7dG
1
378
Dr Timos Papagatsias retweeted
Are you interested in #AbbVie Ventures #CVC and investment portfolio? Gain now 💡 insights into the 2023 📊 BioPharma (+ Google) Corporate Venture Capital Investment Trends ➡️ dlvr.it/Smcw9t CVCs analyzed: #AbbVie Ventures, #Amgen Ventures,… dlvr.it/SmcwB0
1
1
392
Dr Timos Papagatsias retweeted
1
2
559
Dr Timos Papagatsias retweeted
Want to see what #AbbVie and other companies do in the oncology / hematology space? ➡️ dlvr.it/Sm1nVl #oncology #hematology #pharma #abbvie #amgen #astrazeneca #bms #gilead #gsk #janssen #merck #emdserono #lilly #novartis #pfizer #roche… dlvr.it/Sm1nVp
2
2
538
LucidQuest Updates > ESGCT 2026 Preview: Gene and Cell Therapy Trends dlvr.​it/TW40VJ #ConferencePreviews #OurInsights #AAVmanufacturing Comment below!
35
LucidQuest Updates > AAN 2026 Preview: Emerging Neurology Trends and AI dlvr.​it/TW3y3Z #ConferencePreviews #OurInsights #neurology Comment below!
18
1/6 🧬 #ESGCT2026 will put delivery, durability, safety and manufacturing scale under the spotlight. Key competitive shifts: in vivo gene editing, in vivo CAR-T, differentiated AAV platforms and AI-enabled therapeutic design. #LucidQuest's preview: bit.ly/4sohRm5 @ESGCT
1
1
87
5/6 🤖 AI/ML is expanding across capsid design, off-target prediction and bioprocessing. Dyno, Lir, Basecamp and WhiteLab are among the companies to watch. The strategic test: cross-species translation, manufacturing reproducibility and regulatory validation.
1
15
6/6 👀 Post-#ESGCT2026 watchpoints: 🧬 Clinical signals from ATA-200, ETX101 and AVB-406 🧫 AAV durability, hepatic safety and redosing 💸 Manufacturing economics and access 🔗 Explore LucidQuest's ESGCT 2026 preview: bit.ly/4sohRm5 [email protected]
1
21